Giving Compass' Take:

• Global Health NOW highlights a recent global report showing a rise in research funding for neglected diseases, however there could be a debate over it's validity. 

• How can disease funders examine their own data and evaluate their contributions? What specific areas or diseases are lacking the most funding?

• Here's an article on how to find and fund scientific research. 

Funding for neglected diseases that afflict some 1 billion people reached a record high in 2017, commanding $3.6 billion. That’s a 7% jump from 2017 and the most since 2007, according to a new report from Sydney-based think tank Policy Cures Research.

More funding for drugs tackling multiple diseases at once and promising developments for Ebola drugs fueled much of the 2017 surge, Nature reported. A handful of top public sector funders dominated the shift, including the US and India. UK funding rose 89%.

But there were data gaps: The researchers noted that they didn’t have numbers on contributions from Russia and China, BBC reported.

Read the full article about funding research for neglected diseases at Global Health NOW